Our Approach to Holding Drug Companies Responsible On October 6, 2023, Siskinds LLP filed a proposed GLP-1 drug class action in the Supreme Court of British Columbia against Novo Nordisk and affiliated entities on behalf of persons in Canada who were prescribed and used Ozempic, Rybelsus, and/or Wegovy and suffered serious injuries
Meal Management: Eat smaller, more frequent meals throughout the day instead of large ones
[PUBMED Abstract] Azzarello LM, Jacobsen PB: Factors influencing participation in cutaneous screening among individuals with a family history of melanoma
In the SURPASS-EARLY trial, nearly 800 adults diagnosed with type 2 diabetes within the past four years whose disease was not adequately controlled with metformin, diet and exercise were assigned to add either tirzepatide or other medications
This makes oral and parenteral administration of exogenous GSH problematic as it leads to poor accumulation in the CNS (Ronaldson and Davis, 2015)
Insurance Coordinator Our coordination team helps you maximize your insurance coverage for semaglutide or other GLP-1s